Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03552471
Brief Title: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

First Submitted : April 26, 2018
First Submitted that Met QC Criteria : May 29, 2018
First Posted : June 11, 2018

Last Update Submitted that Met QC Criteria : February 23, 2021
Last Update Posted : February 25, 2021